نتائج البحث

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

• Authors : Oncoceutics, Inc.

• Source: Phase I/II Study of Oral ONC201 in Patients With Relapsed or Refractory Acute Leukemias and High-Risk Myelodysplastic Syndromes

تفاصيل العنوان

A Study of ONC201 for Refractory Meningioma

• Authors : Chimerix

• Source: A Pilot Study, Open-Label Study of ONC201 for Refractory Meningioma

تفاصيل العنوان

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

• Source: Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

تفاصيل العنوان

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) (ACTION)

• Source: ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled,

تفاصيل العنوان

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

• Authors : Genentech, Inc.; Oncoceutics, Inc.

• Source: Phase 1 Clinical Trial of ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

تفاصيل العنوان

Oral ONC201 in Relapsed/Refractory Multiple Myeloma

• Authors : Oncoceutics, Inc.

• Source: Oral ONC201 in Relapsed/Refractory Multiple Myeloma

تفاصيل العنوان

ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

• Authors : Ira Winer, Principal Investigator

• Source: Phase II Study of ONC201 Plus Weekly Paclitaxel in Patients With Platinum-Resistant Refractory or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal

تفاصيل العنوان

Testing ONC201 to Prevent Colorectal Cancer

• Source: Phase 1 Trial of ONC201 for Chemoprevention of Colorectal Cancer

تفاصيل العنوان

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

• Authors : Sweha, Stefan; Mota, Mateus; Pun, Matthew

Subjects: Humans; Glioma; Brain Neoplasms

• Source: Cancer Discovery. 13(11)

تفاصيل العنوان

Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer

• Authors : Oncoceutics, Inc.

• Source: A Phase 2 Study of Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer

تفاصيل العنوان